Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImage Scan Holdings Regulatory News (IGE)

Share Price Information for Image Scan Holdings (IGE)

Share Price is delayed by 15 minutes
Get Live Data
2.20    0.45 (25.71%)
Bid:
2.10
Ask:
2.30
Spread: 0.20 (9.524%)
Market Cap: £3.01m
IGE Live PriceLast checked at - London Stock Exchange

Intraday Image Scan Holdings Share Chart

Final Results

2 Dec 2025 07:00

RNS Number : 7699J
Image Scan Holdings PLC
02 December 2025
 

 

 IMAGE SCAN HOLDINGS PLC

("Image Scan" or the "Company")

 

Final Results for the Year Ended 30 September 2025

 

Image Scan (AIM: IGE), the specialist supplier of X-ray screening systems to the security and industrial inspection markets, today announces final results for the year ended 30 September 2025.

HIGHLIGHTS

 

Resilient Performance Against Global Uncertainty - Strong Second-Half Performance, Robust Margins, Strong Cash Position, Strengthened Order Book, and Optimistic Outlook

FINANCIAL HEADLINES

· Order intake £1.9m (2024: £6.6m)

· Sales £1.6m (2024: £2.9m)

· Gross profit margin 58% (2024:53%)

· Administrative expenses £1.2m (2024: £1.3m)

· Pre-tax loss £0.3m (2024: profit £0.2m)

· Year-end order book £4.67m (2024: £4.47m)

· Year-end cash balance £1.13m (2024: £0.91m)

 

Image Scan's Chief Executive, Vince Deery, commented: 

FY25 was a year of contrasts for Image Scan. The first half was marked by global uncertainty and delayed procurement decisions, which impacted our revenues and resulted in a loss for the year. However, I am proud of how the team responded-demonstrating resilience, discipline, and a relentless focus on operational efficiency. 

 

The second half saw a clear turnaround, with improved activity levels, a return to profitable trading, and a robust closing order book. Our cash position is strong, and we continue to invest in product innovation and strategic partnerships to drive future growth.

 

With a healthy pipeline and recent contract wins, we enter FY26 with renewed confidence. I would like to thank our employees, partners, and shareholders for their ongoing support as we build on this momentum and look forward to delivering improved performance in the year ahead.

 

For further information on the Company, please visit: www.ish.co.uk and for further information on its products, please visit: www.3dx-ray.com

 

-ENDS-

 

Image Scan Holdings plc Tel: +44 (0) 1509 817400

Vincent Deery CEO

Sarah Atwell-King, CFO & Company Secretary

 

Zeus - Nominated Advisor and Corporate Broker Tel: +44 (0)203 829 5000

Mike Coe/James Bavister (Investment Banking)

 

 

ABOUT IMAGE SCAN HOLDINGS PLC

About Image Scan Holdings plc

The core activity of the Group is the manufacture of portable X-ray systems for security and counter terrorism applications. The Group recently launched a cabinet X-ray machine and is replacing its Axis range of checkpoint X-ray systems with new machines developed with a partner. All these products are taken to market across the world through a strong network of international partners.

 

In addition, over the last seventeen years, Image Scan has developed and manufactured industrial X-ray inspection systems, the MDXi range. The primary market for these systems is in automotive emissions control where they are used for quality control inspection of catalytic converters and diesel particulate filters.

 

The visibility and reach of the Company's 3DX-Ray brand has been further strengthened through a new LinkedIn profile focussed on its EOD and counter-terrorism activities. This can be found at: https://www.linkedin.com/company/3dx-ray/

 

For further information on the Company, please visit: www.ish.co.uk - and for further information on its products, please visit: www.3dx-ray.com

 

CHAIRMAN'S STATEMENT

Overview

For the year ended 30 September 2025 (the "Year"), the Group generated revenues of £1.6m (2024: £2.9m), and a loss before tax of £0.3m (2024: profit £0.2m). FY25 was a year of contrasts. The first half presented significant challenges, driven by global uncertainty surrounding the new U.S. administration and tariff policies. This hesitation rippled across markets, delaying government spending and procurement decisions worldwide. Despite these headwinds, the team demonstrated resilience and discipline, maintaining tight cost control and operational efficiency. Group cash balances closed at £1.13m (2024: £0.91m), reinforcing our financial strength.

The second half of the year marked a clear turnaround. Activity levels improved, profitability strengthened, and we closed the year with renewed momentum. Our commitment to innovation and market responsiveness remains steadfast, and we continue to invest in product development and strategic partnerships to secure long-term growth.

Outlook

With a strengthened order book, a healthy cash position of £1.13 million, and continued, focused investment in product development, we stand on a solid operational and financial foundation. The continuing success of our flagship ThreatScan portable x-ray platform, coupled with encouraging post-year-end contract awards and a robust pipeline, strongly reinforces our confidence in our ability to deliver substantial growth and a much-improved performance in FY26.

 

Leveraging the collective expertise of our team, and with determination and agility, the Board remains confident in the Group's medium to long-term prospects. We are fully committed to capitalising on the significant operational momentum built in the latter part of the year, which is further reinforced by the subsequent substantial orders notified post year-end. Alongside this, we are actively pursuing focused strategic and organic initiatives that will underpin our future growth trajectory.

 

 

Tim Jackson

CHAIRMAN

 

 

 

 

 

CEO REPORT

BUSINESS REVIEW

FY25 began under the shadow of persistent global economic uncertainty. Concerns around U.S. trade policy and tariffs created hesitation among government organisations, which resulted in delayed procurement cycles across our key international markets. As an exporter, with around 90% of our products going overseas, this environment was particularly challenging, with delays evident across the Middle East, Southeast Asia, and Europe,

 

Throughout the difficult trading conditions in the first half of the year, the Group maintained strict cost discipline and organisational efficiency. Our strategy was focused on proactive engagement and sustaining competitiveness through ongoing product development. This decisive action resulted in a marked improvement in demand and profitability in the second half of the year.

 

Continued, focused investment ensured that our flagship ThreatScan® platform gained further traction, reinforcing our competitive position in international tenders and deliveries to over twenty territories.

 

We were pleased to announce two significant contract awards in August 25 which materially strengthened our order book. The first was for a new customer in North America for our industrial MDXi-400 system a notable achievement given the maturity of this market. The second was for our latest portable ThreatScan® system for an Eastern European military organisation. Additionally, we progressed deliveries of a double-digit quantity of ThreatScan® systems to a Southeast Asian customer. It must be noted, however, that supply chain lead times prevented the completion of key contracts, which limited overall revenue.

 

Our sales team maintained excellent market visibility through participation in key trade shows and Counter Explosive Ordnance conventions. These efforts generated new opportunities and supported robust performance in several geographies, with Europe and Asia delivering particularly strong results, and India returning to growth.

 

Our operational discipline is reflected in our strengthened financial position: our cash position improved significantly during the year, reaching £1.13m at year-end (FY24: £0.91m), a testament to disciplined financial management and active working capital control.

 

Industrial revenues provided stronger-than-anticipated results, as the strength of our recurring income from service and software contracts successfully mitigated the anticipated decline and structural changes in the catalyst-related business, underscoring the Group's adaptability.

 

We continue to seek clarity on the timing of a major UK defence contract. While progress has been significantly slower than expected, recent developments have been positive, though timelines remain dictated by government processes.

 

OUTLOOK

 

We enter FY26 with renewed confidence following a strong second-half performance and a significantly strengthened order book. Market activity levels remain high post-year end, reinforced by recent contract awards, providing a robust order book and a solid foundation for sustained success.

 

We also note that progress on the large UK defence contract has been slower than anticipated. While we are seeing recent positive developments, timelines remain dictated by the pace of government departments, and we continue to work closely with all stakeholders to advance this important opportunity.

 

Continued investment in product development, particularly the ThreatScan® platform, positions us well to maintain competitiveness and access new opportunities. We are committed to reinforcing our global channel network, prioritising engagement at trade shows and industry events, and actively exploring strategic alliances, and partnerships, to accelerate future success and enhance long-term shareholder value. While geopolitical uncertainties remain, the current momentum and high activity levels give us optimism for the year ahead.

 

 

Vincent Deery

CHIEF EXECUTIVE OFFICER

 

 

 

 

 

 

 

CFO REPORT

 

KEY PERFORMANCE INDICATORS

 

2025

2024

2023

2022

2021

Order intake

£1.9m

£6.6m

£2.9m

£2.2m

£2.8m

Turnover

£1.6m

£2.9m

£3.0m

£2.0m

£2.9m

Gross profit margin

58%

53%

48%

54%

53%

Profit/(loss) before tax

(£0.3m)

£0.2m

£0.1m

(£0.4m)

£0.2m

Cash balance

£1,131k

£911k

£958k

£690k

£1,186k

Inventory Balance

£374k

£393k

£349k

£629k

£393k

FINANCIAL RESULTS

FY25 was a difficult year for Image Scan, delivering a pre-tax loss of £288k after two successive years of profit. The stronger second half performance indicate FY25 was an unusual year largely due the impact of global uncertainty leading to governments delaying spends. Notably, our gross margin increased to 58%, the highest on record for the Group. The improved closing bank balances along with the strong order book and underlying opportunity pipeline provides forward looking metrics which give confidence for FY26.

 

 

Sarah Atwell King

CHIEF FINANCIAL OFFICER

 

 

 

 

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

For the year ended 30 September 2025

 

Note

 

2025

£

 

2024

£

REVENUE

1,617,718

2,860,776

Cost of sales

(671,393)

(1,348,975)

 

 

Gross profit

946,325

1,511,801

 

 

Administrative expenses

(1,238,253)

(1,313,730)

Other operating income

-

3,474

 

 

OPERATING (LOSS)/PROFIT

(291,928)

201,545

 

Finance income

7,888

10,736

Interest payable and similar charges

(3,984)

(4,514)

 

 

(LOSS)/PROFIT BEFORE TAXATION

(288,024)

207,767

 

 

Taxation

-

(756)

 

 

 

(LOSS)/PROFIT AND TOTAL COMPREHENSIVE INCOME FOR THE YEAR FROM CONTINUING OPERATIONS ATTRIBUTABLE TO THE EQUITY OWNERS OF THE PARENT COMPANY

(288,024)

207,011

 

 

 

 

 

 

 

 

Pence

Pence

Earnings per share

 

Basic

2

(0.21)

0.15

Diluted

(0.21)

0.15

 

 

 

 

 

CONSOLIDATED STATEMENT OF FINANCIAL POSITION

As at 30 September 2025

 

 

2025

£

 

2024

£

NON-CURRENT ASSETS

Intangible assets

309,733

333,249

Property, plant and equipment

-

-

Right of use asset

79,893

143,873

 

 

 

 

389,626

477,122

 

 

 

CURRENT ASSETS

 

Inventories

374,176

392,643

Trade and other receivables

422,164

910,775

Cash and cash equivalents

1,130,955

911,468

 

 

1,927,295

2,214,886

 

 

 

TOTAL ASSETS

2,316,921

2,692,008

 

 

 

CURRENT LIABILITIES

 

Trade and other payables

776,852

792,167

Lease liability

48,467

53,158

Warranty provision

15,522

25,473

 

 

 

840,841

870,798

 

 

 

NON-CURRENT LIABILITIES

 

Lease liability

45,392

102,498

 

 

 

 

45,392

102,498

 

 

 

 

 

NET ASSETS

1,430,688

1,718,712

 

 

 

EQUITY

 

Share capital

1,368,546

1,368,546

Share premium account

8,332,910

8,332,910

Profit and loss account

(8,270,768)

(7,982,744)

 

 

 

TOTAL EQUITY ATTRIBUTABLE TO SHAREHOLDERS

1,430,688

1,718,712

 

 

 

 

 

STATEMENT OF CHANGES IN EQUITY

For the year ended 30 September 2025

 

CONSOLIDATED

Share capital

£

Share premium

£

Profit and loss account

£

 

Total

£

As at 1 October 2023

1,368,546

8,332,910

(8,189,755)

1,511,701

 

 

Profit for the year and total comprehensive income for the year

-

-

207,011

207,011

 

 

 

 

As at 30 September 2024

1,368,546

8,332,910

(7,982,744)

1,718,712

Loss for the year and total comprehensive income for the year

-

-

(288,024)

(288,024)

 

 

 

 

 

As at 30 September 2025

1,368,546

8,332,910

(8,270,768)

1,430,688

 

 

 

 

 

 

 

CONSOLIDATED CASH FLOW STATEMENT

Year ended 30 September 2025

 

 

2025

£

 

2024

£

Cash flows from operating activities

 

 

 

Operating (loss)/profit

(291,928)

201,545

 

Adjustments for:

 

Amortisation of intangible assets

66,394

62,350

Depreciation

-

7,199

Amortisation of right of use asset

45,584

40,524

Research and development expenditure credit

-

(3,474)

Increase/(decrease) in impairment of inventories

31,838

(9,280)

Increase in inventories

(13,371)

(34,610)

Decrease/(increase) in trade and other receivables

488,611

(300,627)

Decrease/(increase) in trade and other payables

(15,315)

79,712

Decrease in warranty provisions

(9,951)

(8,385)

 

 

 

Cash generated from operating activities

301,862

34,954

Corporation tax received

-

26,440

 

 

 

Net cash flows generated from operating activities

 

301,862

61,394

 

 

 

 

 

Cash flows from investing activities

 

Interest received

7,888

10,736

Purchase of intangibles

(42,878)

(74,642)

Purchase of property, plant and equipment

-

(600)

 

 

Net cash used in investing activities

(34,990)

(64,506)

 

 

CASH FLOWS FROM FINANCING ACTIVITIES

 

Lease payments (capital and interest)

(47,385)

(43,885)

 

 

 

Net cash used in financing activities

 

 

(47,385)

(43,885)

 

 

 

Net INCREASE(DECREASE) in cash and cash equivalents

219,487

(46,997)

Cash and cash equivalents at beginning of year

 

 

911,468

958,465

 

 

 

 

 

Cash and cash equivalents at end of year

 

 

1,130,955

911,468

 

 

 

 

 

 

 

Notes to this statement

1. Basis of preparation

While the financial information included in this annual financial results announcement has been prepared in accordance with the recognition and measurement principles of UK adopted international accounting standards, this announcement does not contain sufficient information to comply therewith.

 

The financial information set out above does not constitute the Group's statutory accounts for the years ended 30 September 2025 or 30 September 2024 but is derived from those accounts. Statutory accounts for 2024 have been delivered to the Registrar of Companies, and those for 2025 will be delivered following the Company's Annual General Meeting. The auditors have reported on those accounts; their reports were unqualified and did not contain statements under Section 498 of the Companies Act 2006.

 

2. Earnings per share

The diluted earnings per share is calculated by adjusting the weighted average number of ordinary shares in issue on the assumption of conversion of dilutive potential ordinary shares. The Company's dilutive potential ordinary shares are shares issued under the Company's Enterprise Management Incentive ('EMI') scheme and options issued under the Company's Unapproved scheme. Where the Company is reporting losses, the impact of share options is considered anti-dilutive. Where the Company is reporting profits, share options could potentially dilute basic earnings per share in the future but are only included in the calculation of diluted earnings per share when the exercise price of the share options is below the average share price in the year.

  

 

2025

£

2024

£

(Loss)/profit for the year

(288,024)

207,011

 

 

Weighted average number of ordinary shares in issue

136,854,577

136,854,577

Number of diluted shares

136,854,577

136,854,577

 

 

Basic (loss)/profit per share

(0.21p)

0.15p

Diluted (loss)/profit per share

(0.21p)

0.15p

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FR PKDBQOBDDQBK
Date   Source Headline
5th Jun 20269:45 amRNSContract Award
30th Apr 20267:00 amRNSInterim Results
25th Feb 20262:27 pmRNSResult of AGM
25th Feb 20267:00 amRNSAGM Statement
2nd Feb 20267:00 amRNSUpdate on Defence Contract with NP Aerospace
21st Jan 20261:31 pmRNSNotice of AGM and Posting of Annual Report
2nd Dec 20257:00 amRNSFinal Results
18th Nov 20257:00 amRNS-RContract Award
11th Nov 20257:00 amRNSNew Contract Award
4th Nov 20257:00 amRNSTrading Update
2nd Sep 202511:23 amRNSHolding(s) in Company
21st Aug 20257:00 amRNSTrading Update And New Contract Awards
20th May 20258:32 amRNSInterim Results
14th May 202511:55 amRNSHolding(s) in Company
26th Feb 20252:38 pmRNSResult of AGM
26th Feb 20257:00 amRNSAGM Statement
15th Jan 202510:48 amRNSNotice of AGM & Posting of Annual Report
3rd Dec 20247:00 amRNSFinal Results
23rd Oct 20247:00 amRNSTrading Update
16th Oct 20247:00 amRNSContract Award Update
4th Sep 20247:00 amRNSHolding(s) in Company
21st Aug 20247:00 amRNSHolding(s) in Company
7th Aug 20247:00 amRNSHolding(s) in Company
5th Aug 20247:00 amRNSHolding(s) in Company
24th Jul 20247:00 amRNSHolding(s) in Company
15th Jul 20247:00 amRNSChange of Adviser
4th Jul 20247:00 amRNSContract Award
12th Jun 20247:00 amRNSContract award worth over £350k
20th May 20244:33 pmRNSHolding(s) in Company
30th Apr 20247:00 amRNSInterim Results
29th Apr 20247:00 amRNSInitial c£300k order for new Portable X-Ray System
12th Mar 20247:00 amRNSLaunch of AXIS-CXi Cabinet with AI Software
28th Feb 20242:48 pmRNSResult of AGM
28th Feb 20247:00 amRNSTrading Statement
26th Jan 20241:50 pmRNSHolding(s) in Company
18th Jan 20241:28 pmRNSHolding(s) in Company
11th Jan 20243:06 pmRNSHolding(s) in Company
9th Jan 202412:46 pmRNSNotice of AGM & Posting of Annual Report
9th Jan 202412:00 pmRNSHolding(s) in Company
22nd Dec 20231:30 pmRNSHolding(s) in Company
12th Dec 20237:00 amRNSFinal Results
10th Oct 20237:00 amRNSTrading Update
11th Sep 20237:00 amRNS2023 orders to over 30 countries
4th Jul 20237:00 amRNSHolding(s) in Company
26th Apr 20237:00 amRNSInterim Results
13th Mar 20239:34 amRNSHolding(s) in Company
28th Feb 20233:03 pmRNSResult of AGM
28th Feb 20237:00 amRNSTrading Statement
10th Feb 20231:26 pmRNSHolding(s) in Company
26th Jan 202312:09 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.